BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 31749596)

  • 21. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
    Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
    J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy.
    Mu GC; Huang Y; Liu ZM; Wu XH; Qin XG; Chen ZB
    BMC Gastroenterol; 2019 Nov; 19(1):188. PubMed ID: 31729975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
    Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.
    Hirabayashi S; Kosugi S; Isobe Y; Nashimoto A; Oda I; Hayashi K; Miyashiro I; Tsujitani S; Kodera Y; Seto Y; Furukawa H; Ono H; Tanabe S; Kaminishi M; Nunobe S; Fukagawa T; Matsuo R; Nagai T; Katai H; Wakai T; Akazawa K
    Ann Oncol; 2014 Jun; 25(6):1179-84. PubMed ID: 24669009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer.
    Bando E; Ji X; Kattan MW; Seo HS; Song KY; Park CH; Bencivenga M; de Manzoni G; Terashima M
    Cancer Med; 2020 Aug; 9(16):5708-5718. PubMed ID: 32588982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
    BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prognostic Model Based on Clinicopathological Features and Inflammation- and Nutrition-Related Indicators Predicts Overall Survival in Surgical Patients With Tongue Squamous Cell Carcinoma.
    Wei LF; Huang XC; Lin YW; Luo Y; Ding TY; Liu CT; Chu LY; Xu YW; Peng YH; Guo HP
    Technol Cancer Res Treat; 2021; 20():15330338211043048. PubMed ID: 34866500
    [No Abstract]   [Full Text] [Related]  

  • 28. A Nomogram Based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) Ratio to Predict Prognosis After Surgery in Gastric Cancer Patients.
    Li L; Zeng Q; Xue N; Wu M; Liang Y; Xu Q; Feng L; Xing S; Chen S
    Cancer Control; 2020; 27(1):1073274820954458. PubMed ID: 32959672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
    Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
    World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer].
    Cong X; Li S; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
    Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
    Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and external validation of a nomogram for predicting the conditional probability of survival after D2 lymphadenectomy for gastric cancer: A multicentre study.
    Chen QY; Zhong Q; Wang W; Desiderio J; Liu ZY; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Zhou ZW; Parisi A; Huang CM
    Eur J Surg Oncol; 2019 Oct; 45(10):1934-1942. PubMed ID: 31027946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy.
    Wang N; Xi W; Lu S; Jiang J; Wang C; Zhu Z; Yan C; Liu J; Zhang J
    Front Oncol; 2021; 11():650562. PubMed ID: 34195071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rationality of N3 classification and its sub-classification in TNM classification system for advanced gastric cancer].
    Cheng Y; Huang J; Zhu Z; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):749-55. PubMed ID: 27452751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.
    Han DS; Suh YS; Kong SH; Lee HJ; Choi Y; Aikou S; Sano T; Park BJ; Kim WH; Yang HK
    J Clin Oncol; 2012 Nov; 30(31):3834-40. PubMed ID: 23008291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.